Each vial contains 2.5mg of highly pure AOD-9604.
AOD-9604 is a synthetic peptide fragment derived from the C-terminal region of human growth hormone (hGH), specifically engineered to isolate and study the lipolytic (fat-metabolizing) properties of hGH without its broader anabolic or growth-promoting effects. It is commonly investigated for its role in regulating fat metabolism, lipid mobilization, and body composition in controlled research settings.
This peptide functions by mimicking the fat-reducing segment of hGH, stimulating lipolysis—the breakdown of stored triglycerides into free fatty acids—while simultaneously inhibiting lipogenesis, the process by which new fat is formed. Through this dual mechanism, AOD-9604 supports enhanced fat utilization and may contribute to reductions in adipose tissue under experimental conditions.
Unlike full-length growth hormone, AOD-9604 does not appear to significantly influence insulin-like growth factor-1 (IGF-1) levels or promote cell proliferation. This targeted activity allows researchers to examine fat metabolism pathways without the confounding systemic effects typically associated with hGH, such as increased tissue growth or alterations in blood glucose regulation.
Preclinical studies suggest that AOD-9604 may enhance metabolic efficiency by increasing the rate at which stored fat is oxidized for energy. These effects are associated with improved lipid profiles and may support investigations into obesity-related metabolic dysfunction and weight regulation.
In addition to its lipolytic properties, AOD-9604 has been explored for its potential influence on cartilage and tissue repair processes, though these effects remain secondary to its primary metabolic focus. Ongoing research continues to evaluate its broader physiological impact and long-term safety profile.
AOD-9604 is primarily utilized in laboratory and experimental research to study fat metabolism, obesity pathways, and metabolic regulation. Its selective mechanism makes it a useful tool for isolating the metabolic actions of growth hormone-derived peptides without systemic endocrine effects.
Key Points
Action:
Stimulates lipolysis and inhibits lipogenesis, promoting the breakdown and utilization of stored fat while minimizing effects on growth-related pathways.
Indications:
Used in research related to obesity, fat metabolism, weight regulation, and metabolic efficiency.
Difference from Growth Hormone-Based Compounds:
AOD-9604 isolates the fat-reducing segment of growth hormone, providing targeted metabolic activity without significantly affecting IGF-1 levels or inducing systemic growth-related effects.
